| Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231) |
|---|
| 06/17/2004 | WO2004049907A2 Compositions and methods for treating transplants |
| 06/17/2004 | WO2004038401A3 Biosensor having hematocrit and oxygen biases |
| 06/17/2004 | WO2004034013A8 Genotoxicity analysis |
| 06/17/2004 | WO2004031233A9 Novel chemokine-like polypeptides |
| 06/17/2004 | WO2004029618A3 Methods to predict cholesterol elevations during immunosuppressant therapy |
| 06/17/2004 | WO2004027421A3 Adp assay |
| 06/17/2004 | WO2004027379A3 Methods and devices for active bioassay |
| 06/17/2004 | WO2004027090A3 Method for differentiating chondrocytes, which are capable of forming an extracellular cartilaginous matrix, from chondrocytes, which do not have this capability, by determining the gene expression status |
| 06/17/2004 | WO2004025262A3 Membrane-based assays |
| 06/17/2004 | WO2004023091A3 Localization of human cytomegalovirus nucleic acids and proteins in human cancer cells |
| 06/17/2004 | WO2004021000A9 Immunocapture-based measurements of mammalian pyruvate dehydrogenase complex |
| 06/17/2004 | WO2004020668A3 Method for treating synovial sarcoma |
| 06/17/2004 | WO2004018640A3 Preservation of rna quality and content in tissue sections during immunohistochemistry |
| 06/17/2004 | WO2004018497A3 Modified nucleotides for polynucleotide sequencing |
| 06/17/2004 | WO2004016742A3 α(1,3)-GALACTOSYLTRANSFERASE NULL CELLS, METHODS OF SELECTING AND α(1,3)-GALACTOSYLTRANSFERASE NULL SWINE PRODUCED THEREFROM |
| 06/17/2004 | WO2004016156A3 Dynamic hepatic recycling glucose tolerance test |
| 06/17/2004 | WO2004011677A3 Viral marker |
| 06/17/2004 | WO2004007742A3 Chromosome 6 and 9 genes involved in premature canities |
| 06/17/2004 | WO2004005888A3 Method for metal analysis and speciation and biosensor for effecting the method |
| 06/17/2004 | WO2004001071A3 Genetic predisposition analysis and treatment |
| 06/17/2004 | WO2003106660A3 Immunomodulation and effect on cell processes relating to serotonin family receptors and the blood-brain barrier |
| 06/17/2004 | WO2003102235A3 Specific genetic markets for cytogenetically defined acute myeloid leukaemia |
| 06/17/2004 | WO2003102213A3 Error-prone dna polymerase i mutants and methods for targeted random mutagenesis in continuous culture using error-prone dna polymerase i mutants |
| 06/17/2004 | WO2003102212A3 In vitro evaluation of nucleic acid ligands |
| 06/17/2004 | WO2003095491A3 Antibody screening libraries |
| 06/17/2004 | WO2003087405A3 Method for characterizing primary tumors |
| 06/17/2004 | WO2003073351A3 Screening process |
| 06/17/2004 | WO2003071281A3 Estrogen receptor interaction with a transcription factor |
| 06/17/2004 | WO2003070162A3 Par-3 compounds for therapy and diagnosis and methods for using same |
| 06/17/2004 | WO2003062791A3 Detection of single nucleotide polymorphisms using planar waveguides |
| 06/17/2004 | WO2003062402A3 Use of collections of binding sites for sample profiling and other applications |
| 06/17/2004 | WO2003060467A3 Method for analyzing effects of medical agents |
| 06/17/2004 | WO2003058199A3 Arrays of microparticles and methods of preparation thereof |
| 06/17/2004 | WO2003053997A3 Methods of increasing endogenous erythropoietin (epo) |
| 06/17/2004 | WO2003051174A3 Single nucleotide polymorphisms and mutations on alpha-2-macroglobulin |
| 06/17/2004 | WO2003044528A3 Flow-controlled magnetic particle manipulation |
| 06/17/2004 | WO2003039341A3 Methods and compositions to treat cardiovascular disease using 139, 258, 1261, 1486, 2398, 2414, 7660, 8587, 10183, 10550, 12680, 17921, 32248, 60489 or 93804 |
| 06/17/2004 | WO2003034073A3 Method and kit for monitoring recruitment of proteins to the intracellular domain of a receptor in intact cells |
| 06/17/2004 | WO2003033744A9 Methods for determining multiple effects of drugs that modulate function of transcription regulatory proteins |
| 06/17/2004 | WO2003033648A3 Imaging the activity of extracellular proteases in cells using mutant anthrax toxin protective antigens that are cleaved by specific extracellular proteases |
| 06/17/2004 | WO2003032810A3 Treatment and diagnosis of insulin resistant states |
| 06/17/2004 | WO2003026566A3 Atlastin |
| 06/17/2004 | WO2003017992A3 Means for treatment of atherosclerosis |
| 06/17/2004 | WO2003015689A3 Pharmaceutical composition for the prophylaxis and/or treatment of virus diseases |
| 06/17/2004 | WO2002103028A3 In silico screening for phenotype-associated expressed sequences |
| 06/17/2004 | WO2002086443A8 Methods of diagnosis of lung cancer, compositions and methods of screening for modulators of lung cancer |
| 06/17/2004 | WO2002086065A3 Induction of apoptosis by cellular stress |
| 06/17/2004 | WO2002079419A3 Identifying and characterizing genes |
| 06/17/2004 | WO2002064015A3 Pin1 as a marker for prostate cancer |
| 06/17/2004 | WO2002022857A8 Methods for the identification of modulators of magnesium chelatase expression or activity in plants |
| 06/17/2004 | US20040117871 Plant growth regulation |
| 06/17/2004 | US20040117870 Transgenic glyphosate resistant sugar beet; disease and herbicide resistant plants |
| 06/17/2004 | US20040117867 Zebrafish animal models for clarifying gene function relationships in hyperproliferative disorders; antisense agents; RNA interference and tumor treatment therapies |
| 06/17/2004 | US20040117865 Transposon generated genetically engineered rodent for use as tool in clarifying gene function; gene therapy and transposon mediated transformation |
| 06/17/2004 | US20040117348 Sequence display method and homology search method for facilitating access to information relating to regions of mutation and regions of similarity between plurality of sequences |
| 06/17/2004 | US20040117343 Methods for profiling and classifying tissue using a database that includes indices representative of a tissue population |
| 06/17/2004 | US20040117130 System and method for improving the accuracy of DNA sequencing and error probability estimation through application of a mathematical model to the analysis of electropherograms |
| 06/17/2004 | US20040117129 Detection of biological warfare ; amlification, hybridizing nucleic acids |
| 06/17/2004 | US20040116689 can comprise DNA, RNA, PNA, or any combination or chimera thereof |
| 06/17/2004 | US20040116678 Cardiac hypertrophy factor and uses therefor |
| 06/17/2004 | US20040116672 Human sel-10 polypeptides and polynucleotides that encode them |
| 06/17/2004 | US20040116662 Comprises viral glycoprotein fusion with glutathione s-tranferase (GST) or thioredoxin for use as diagnostic tool in screening blood products for retroviral infection |
| 06/17/2004 | US20040116661 Virulence peptides from attenuated microorganism for identifying microbiocides and developing vaccines which prevent infection; veterinary medicine |
| 06/17/2004 | US20040116658 Human KAP/Cdi1-related gene variant associated with small cell lung cancer |
| 06/17/2004 | US20040116372 to decrease the number of cells which may accumulate in chronic inflammatory disease by enhancing apoptosis at the site of increased cell number via gene therapy |
| 06/17/2004 | US20040116368 Methods for detecting and adjusting replication of hepatitis b virus and for preparing mutated virus strains with altered replication efficiency |
| 06/17/2004 | US20040116347 Contacting a cell comprising a compound, determining the effect of the compound upon the cell comprising the polypeptide or fragment thereof, thereby identifying a compound that modulates |
| 06/17/2004 | US20040116342 Therapeutic use of a SMR1-peptide or a pharmaceutically active amount of SMR1-peptide, for the preparation of a therapeutic formulation for preventing or treating diseases wherein a modulation of activity of a membrane metallopeptidase is sought |
| 06/17/2004 | US20040116333 Administering to the individual a multimeric compound that binds to at least two P-Selectin Glycoprotein Ligand 1 (PSGL-1) proteins on the surface of a T cell to induces a signal transduction pathway that results in the death of the T cell |
| 06/17/2004 | US20040115833 Temperature cycles of polynucleotides, or polypeptides; mixture containing a buffer solution |
| 06/17/2004 | US20040115814 Using site specific recombination to insert heterologous nucleotide sequences into genomes and monitor transcritional expression in cells; stable, high level expression systems |
| 06/17/2004 | US20040115813 Using differential colorimetric analysis to determine heterogeneity of tumors; diagnosis and characterization of poliferation products |
| 06/17/2004 | US20040115811 Method for the selection of recombination clones comprising a sequence encoding an antidote protein to a toxic molecule |
| 06/17/2004 | US20040115807 O-2a progenitors multipotent cells from neurohypophysis |
| 06/17/2004 | US20040115797 Biochip measuring method and measuring equipment |
| 06/17/2004 | US20040115796 Instrument for detecting light emitted by the contents of a reaction receptacle |
| 06/17/2004 | US20040115794 Methods for detecting transcriptional factor binding sites |
| 06/17/2004 | US20040115787 Subfamily of RNA helicases which are modulators of the fidelity of translation termination and uses thereof |
| 06/17/2004 | US20040115786 Comprises arsenic repressor binding protein (ARSR) for use as transcriptional regulator in genetic engineering; arsenic detection system |
| 06/17/2004 | US20040115773 Serpin in bifidobacteria |
| 06/17/2004 | US20040115772 Methods of inhibiting Helicobacter pylori |
| 06/17/2004 | US20040115761 Polypeptides and nucleic acids encoding same |
| 06/17/2004 | US20040115757 Method of monitoring biofouling in membrane separation systems |
| 06/17/2004 | US20040115756 Determining antibiotic susceptibility of microorganism; treating infections; veterinary medicine |
| 06/17/2004 | US20040115754 Method for establishing a long-term profile of blood sugar level aiding self-control of the same |
| 06/17/2004 | US20040115753 Determining concentration of enoxaparin in blood; monitoring and treating venous thromboembolic disorders; anticoagulants |
| 06/17/2004 | US20040115752 Method for testing samples containing prion protein for the possible presence of the prpsc form |
| 06/17/2004 | US20040115745 Detection of ovarian cancer |
| 06/17/2004 | US20040115742 Method to identify specific interaction between ligand and receptor |
| 06/17/2004 | US20040115731 Microfluidic protein crystallography |
| 06/17/2004 | US20040115730 Test for transmissible spongiform encephalopathies |
| 06/17/2004 | US20040115727 Preparing tetanus and botulinum neurotoxin light chains having altered protease specificity for treatment of neurological or neurodegenerative disorders |
| 06/17/2004 | US20040115723 Hybridization method and hybridization equipment |
| 06/17/2004 | US20040115722 Solid support comprising immobilized probes which are useful in diagnostic screening and gene expression analysis |
| 06/17/2004 | US20040115720 High throughput automatic nucleic acid isolation and quantitation methods |
| 06/17/2004 | US20040115719 Method and apparatus for analyzing a base sequence |
| 06/17/2004 | US20040115718 Identifying and quantifying single stranded RNA sequences associated with viral and bacterial infection; disease diagnosis |
| 06/17/2004 | US20040115717 Identifying nucleotide sequence mutations in breast cancer genes; tumor diagnosis and prognosis |
| 06/17/2004 | US20040115716 Identifying oligonucleotide subsequences associated with gene exprssion inhibition |
| 06/17/2004 | US20040115715 Mismatch repair protein (MSH-5) for diagnosis, prognosis and treatment of cancer and urogenital disorders |